Skip to main content
. 2019 Dec 2;9(12):e029475. doi: 10.1136/bmjopen-2019-029475

Table 4.

Risk of bias assessment for preclinical studies

Author, Year Random Sequence Generation Allocation Concealment Blinding of Personnel Blinded Outcome Assessment Incomplete Outcomes Addressed Selective Outcome Reporting Conflicts of Interest A Priori Sample Size Calculation Funding
Cooke, 201624 Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear High Risk
Cooke, 201522 Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear High Risk
Piasecki, 201523 Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear High Risk
Piasecki, 201321 Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear High Risk
Liu, 200320 Unclear Unclear Unclear Unclear Low risk Unclear Unclear Unclear High Risk